Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation

被引:137
作者
Boxer, RB
Jang, JW
Sintasath, L
Chodosh, LA [1 ]
机构
[1] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.ccr.2004.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recent studies of oncogene dependence in conditional transgenic mice have suggested the exciting possibility that transient or prolonged MYC inactivation may be sufficient for sustained reversal of the tumorigenic process. In contrast, we report here that following oncogene downregulation, the majority of c-MYC-induced mammary adenocarcinomas grow in the absence of MYC overexpression. In addition, residual neoplastic cells persist from virtually all tumors that do regress to a nonpalpable state and these residual cells rapidly recover their malignant properties following MYC reactivation or spontaneously recur in a MYC-independent manner. Thus, MYC-induced mammary tumor cells subjected to either brief or prolonged MYC inactivation remain exquisitely sensitive to its oncogenic effects and characteristically progress to a state in which growth is MYC-independent.
引用
收藏
页码:577 / 586
页数:10
相关论文
共 21 条
[1]
Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[2]
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations [J].
D'Cruz, CM ;
Gunther, EJ ;
Boxer, RB ;
Hartman, JL ;
Sintasath, L ;
Moody, SE ;
Cox, JD ;
Ha, SI ;
Belka, GK ;
Golant, A ;
Cardiff, RD ;
Chodosh, LA .
NATURE MEDICINE, 2001, 7 (02) :235-239
[3]
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[4]
Reversible tumorigenesis by MYC in hematopoietic lineages [J].
Felsher, DW ;
Bishop, JM .
MOLECULAR CELL, 1999, 4 (02) :199-207
[5]
Transient excess of MYC activity can elicit genomic instability and tumorigenesis [J].
Felsher, DW ;
Bishop, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3940-3944
[6]
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes [J].
Fisher, GH ;
Wellen, SL ;
Klimstra, D ;
Lenczowski, JM ;
Tichelaar, JW ;
Lizak, MJ ;
Whitsett, JA ;
Koretsky, A ;
Varmus, HE .
GENES & DEVELOPMENT, 2001, 15 (24) :3249-3262
[7]
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis [J].
Gunther, EJ ;
Moody, SE ;
Belka, GK ;
Hahn, KT ;
Innocent, N ;
Dugan, KD ;
Cardiff, RD ;
Chodosh, LA .
GENES & DEVELOPMENT, 2003, 17 (04) :488-501
[8]
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology [J].
Gunther, EJ ;
Belka, GK ;
Wertheim, GBW ;
Wang, J ;
Hartman, JL ;
Boxer, RB ;
Chodosh, LA .
FASEB JOURNAL, 2002, 16 (03) :283-292
[9]
Reversibility of acute B-cell leukaemia induced by BCR-ABL1 [J].
Huettner, CS ;
Zhang, P ;
Van Etten, RA ;
Tenen, DG .
NATURE GENETICS, 2000, 24 (01) :57-60
[10]
Sustained loss of a neoplastic phenotype by brief inactivation of MYC [J].
Jain, M ;
Arvanitis, C ;
Chu, K ;
Dewey, W ;
Leonhardt, E ;
Trinh, M ;
Sundberg, CD ;
Bishop, JM ;
Felsher, DW .
SCIENCE, 2002, 297 (5578) :102-104